Monday 19 April 2021
Home      All news      Contact us      RSS     
Yale - 2 month ago

Immunotherapy drug delays onset of Type 1 diabetes in at-risk group

More than five years after receiving an experimental drug, half of a group of people at high risk of developing Type 1 diabetes remained disease-free.


Latest News
Hashtags:   

Immunotherapy

 | 

delays

 | 

onset

 | 

diabetes

 | 

group

 | 

Sources